US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewM
MOLN
MOLECULAR PARTNERS AG
4.01
-0.03-0.85%Closed16:10 01/22 EST
OPEN/PREV CLOSE4.060/4.044
TODAY RANGE3.994-4.080
VOL5.38K
MARKET CAP149.96M
52 WEEK RANGE3.360-5.35
AVG VOL (3M)6.27K
% TURNOVER0.01%
TURNOVER0
P/E (TTM)-5.0265
% RANGE2.23%
EPS(TTM)-0.7977
P/E(FORWARD)-2.1322
P/B1.249
BVPS3.211
DIVIDEND--
P/S16.11
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP149.96M
SHARES OUTSTANDING37.40M
NEXT EARNINGS--
FREE FLOAT37.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Molecular Partners (MOLN) Gets a Buy from LifeSci Capital
TipRanks·01/11 20:55
Molecular Partners provided update on latest progress, 2026 milestones
Reuters·01/11 20:02
MOLECULAR PARTNERS AG - PHASE 2 TRIAL OF MP0317 OPEN FOR CHOLANGIOCARCINOMA
Reuters·12/18/2025 06:00
Molecular Partners AG to Present Latest Developments at J.P. Morgan Healthcare Conference
TipRanks·12/11/2025 12:20
Molecular Partners forms Scientific Advisory Board
TipRanks·12/08/2025 18:05
Promising Pipeline and Strategic Focus Drive Buy Rating for Molecular Partners
TipRanks·12/08/2025 17:20
Molecular Partners price target lowered to CHF 3 from CHF 3.50 at JPMorgan
Benzinga·12/08/2025 16:10
JP Morgan Maintains Neutral on Molecular Partners, Lowers Price Target to $3.75
TipRanks·12/08/2025 13:27
Molecular Partners Presents Promising MP0533 Trial Data at ASH Meeting
Same Industry
Name/Symbol
Change%
Price